Category: Retinal diseases
Age-related macular degeneration in 2025- opportunities and challenges
Where are we now with nAMD? The efficacy of anti-VEGF therapy for nAMD is undisputed. Nonetheless, maintenance of vision in the long-term remains a challenge…